Literature DB >> 18371750

Comparison of different water-miscible solvents for the preparation of plasma and urine samples in metabolic profiling studies.

Muhammed Alzweiri1, David G Watson, Chris Robertson, Graeme J Sills, John A Parkinson.   

Abstract

The Lowry method and a capillary electrophoresis method were used to analyse protein residues in the supernatant after solvent deproteination of plasma. Acetonitrile and acetone were much more effective than methanol and ethanol at reducing the levels of proteins in plasma. The ability of different solvents to decrease levels of phospholipids in plasma samples was assessed using electrospray ionisation mass spectrometry (MS). Phospholipid signals can obscure differences between samples in general metabolite profiling (i.e. non-target compound) studies. Acetonitrile was much more effective than methanol in reducing the MS signal due to phospholipids in plasma which is a consequence of the poor solubility of phospholipids in acetonitrile. The capability of the solvents at reducing salts in urine samples was also studied by using an amperometric method. Using this approach little difference was detected between methanol, ethanol, acetonitrile and acetone in their ability to desalt urine samples.

Entities:  

Mesh:

Substances:

Year:  2007        PMID: 18371750     DOI: 10.1016/j.talanta.2007.07.037

Source DB:  PubMed          Journal:  Talanta        ISSN: 0039-9140            Impact factor:   6.057


  2 in total

1.  An untargeted fecal and urine metabolomics analysis of the interplay between the gut microbiome, diet and human metabolism in Indian and Chinese adults.

Authors:  Abhishek Jain; Xin Hui Li; Wei Ning Chen
Journal:  Sci Rep       Date:  2019-06-24       Impact factor: 4.379

2.  Validation of a LC-MS/MS method for quantifying urinary nicotine, six nicotine metabolites and the minor tobacco alkaloids--anatabine and anabasine--in smokers' urine.

Authors:  James E McGuffey; Binnian Wei; John T Bernert; John C Morrow; Baoyun Xia; Lanqing Wang; Benjamin C Blount
Journal:  PLoS One       Date:  2014-07-11       Impact factor: 3.240

  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.